E Fund Management »

Tg Therapeutics shares owned by E Fund Management

Quarter-by-quarter ownership of Tg Therapeutics (TGTX) shares owned by E Fund Management from 13F filings

Historical chart of E Fund Management investment in Tg Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Tg Therapeutics held by E Fund Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Tg Therapeutics by E Fund Management

Quarter filed Position value Share count Share price at filing
2026-03-31 $16k 492 33.22

More positions owned by E Fund Management

iShares Core S&P 500 ETF Core S&p500 Etf (IVV)
PDD Holdings Sponsored Ads (PDD)
NVIDIA Corporation (NVDA)
State Street SPDR S&P 500 ETF Tr Unit (SPY)
Apple (AAPL)
Yum China Holdings (YUMC)
Microsoft Corporation (MSFT)
Amazon (AMZN)
Newmont Mining Corporation (NEM)
Broadcom (AVGO)
H World Group Sponsored Ads (HTHT)
Meta Platforms Cl A (META)
Agnico (AEM)
Alphabet Cap Stk Cl C (GOOG)
Alphabet Cap Stk Cl A (GOOGL)

View all positions for E Fund Management

Top funds holding Tg Therapeutics

BlackRock
Vanguard Group
State Street Corporation
Vanguard Portfolio Management
Vanguard Capital Management
Soleus Capital Management
Geode Capital Management
ClearBridge Advisors
Jane Street
Goldman Sachs Group
Susquehanna International
Citadel Advisors
Congress Asset Management
Pictet Asset Management Holding SA
Hood River Capital Management

View all funds holding Tg Therapeutics